Biotechnology

World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers

* Phase 1A/1B safety and efficacy trials in Singapore completed within 8 months * TY014 also found to prevent vaccine related adverse effects in vaccinated volunteers SINGAPORE, Nov. 14, 2019 /PRNewswire/ -- Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF)...

2019-11-14 11:07 277

Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner

VISTA, Calif., Nov. 14, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading ...

2019-11-14 08:00 261

China Biologic Reports Financial Results for the Third Quarter of 2019

BEIJING, Nov. 13, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the third quarter of 2019. Third Quarter...

2019-11-14 05:43 682

Merck Licenses CRISPR Gene-Editing Technology to Evotec

-- License to accelerate research, enable testing and development of new drugs DARMSTADT, Germany, Nov. 12, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingEvotec SE access to Merck's foundational CRISPR intelle...

2019-11-12 21:00 463

Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens , a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP campaign on Indiegogo. The device follows the success of the Company's fir...

2019-11-12 20:18 369

AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

SEATTLE, Nov. 12, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at theirSeattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of...

2019-11-12 20:00 370

ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders

BERLIN and TORONTO, Nov. 11, 2019 /PRNewswire/ -- ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, andCyclica Inc., a leading biotechnology company that leverages artificial intelligence and computational biophysics to streamline the drug discovery proce...

2019-11-11 21:45 442

Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director

HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independen...

2019-11-11 19:30 2690

Akeso, Inc. Completes Series-D Private Financing for US$150 Million

ZHONGSHAN, China, Nov. 9, 2019 /PRNewswire/ -- Akeso, Inc. (hereinafter referred to as "Akeso") announced the completion of its Series-D private financing for nearlyUS$150 million, which was co-led in investment by Loyal Valley Capital ("LVC") and Sino Biopharmaceutical Co. Ltd. ("Sino Biopharm")...

2019-11-09 00:43 1335

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

MADISON, Wisconsin, Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed itspreviously announced combination with Genomic Health, Inc. (NASDAQ: GHDX). "Today marks a pivotal step toward building the world's leading advanced cancer diagnostics co...

2019-11-08 21:24 5547

Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent

Largest Set of MIGS Data Ever Produced in Australia Includes Over 900 Eyes with 200+ Stand-Alone Glaucoma Procedures IRVINE, California, Nov. 8, 2019 /PRNewswire/ -- Ivantis today announced long term results of the Australian cohort of the Global SPECTRUM registry. SPECTRUM is a post market pati...

2019-11-08 03:00 536

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost

PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...

2019-11-07 21:02 564

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost

PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...

2019-11-07 20:24 358

TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma

NANJING, China, Nov. 7, 2019 /PRNewswire/ -- TransThera Biosciences Co. Ltd, announced today that company received Orphan Drug Designation from US Food and Drug Administration (FDA) for TT-00420, a clinical stage investigational drug, for the treatment of cholangiocarcinoma. Dr. Frank Wu, Founde...

2019-11-07 20:08 287

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...

2019-11-07 19:04 5355

First Asia-Pacific hospital treats patients with RayStation and Radixact

SUNNYVALE, California, Nov. 7, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) –Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in theAsia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® w...

2019-11-07 09:00 468

EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports

PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" inS...

2019-11-06 18:01 385

Nanoform Wins the CPhI Excellence in Pharma Award for Formulation

HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation...

2019-11-06 17:21 362

WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- WuXi AppTec announced today that it has received investment grade corporate credit ratings from three global rating agencies: Moody's (Baa3), S&P Global Ratings (BBB-), and Fitch Ratings (BBB-); all three agencies maintain a stable outlook on WuXi AppTec. Th...

2019-11-06 16:00 245

Wiley Partners With Editage to Enhance and Expand Services for Authors

LONDON, Nov. 6, 2019 /PRNewswire/ -- John Wiley & Sons Inc. is pleased to announce a new partnership with Editage, a leading global scholarly communications brand by Cactus Communications (CACTUS), to enhance and expand the services available from Wiley Editing Services. This partnership enables ...

2019-11-06 11:00 554
12345 ... 148